Liat Schwartz-Sagi

Liat Schwartz-Sagi, MD, is an experienced clinical research medical director currently at Amgen since June 2022. Prior to this role, Liat served as medical director in safety science at BioMarin Pharmaceutical Inc. from April 2020 to June 2022 and as medical safety director at Acerta Pharma B.V. from March 2017 to April 2020, where responsibilities included leading safety for oncology clinical trials and contributing to global filing efforts. Liat also held the position of senior safety scientist in oncology at Genentech from February 2013 to January 2017, playing a key role in filing activities for breakthrough designations. Earlier experience includes work as an internist and geriatrician at Clalit Health Services, as well as a travel medicine consultant and resident in internal medicine at Clalit Health Services. Liat obtained an MD in medicine from Tel Aviv University.